Key result
In patients with mechanical prosthetic heart valves on warfarin, 48.5% had a suboptimal time in therapeutic range (<60%), strongly associated with higher target INR ranges (OR 8.215 for 3.0-4.0).
Why the study?
Quality of warfarin therapy in patients with a mechanical prosthetic heart valve had been barely investigated.
What are the clinical determinants of low time in the therapeutic range (TiTR <60%) in patients with mechanical prosthetic heart valves receiving warfarin?
Population
2111 patients with MPHVs from the nationwide PLECTRUM study
Design
Nationwide observational study
Authors
Loading...
Suboptimal TTR in mechanical valve patients warrants closer INR monitoring with higher targets; extends predictors of poor control and leaves open alternative strategies.
Observational (n=2,111)
Yes
What are the clinical determinants of low time in the therapeutic range (TiTR <60%) in patients with mechanical prosthetic heart valves receiving warfarin?
Nearly half of patients with mechanical prosthetic heart valves have suboptimal warfarin anticoagulation (TiTR <60%), with higher target INR ranges and comorbidities like diabetes and hypertension being significant predictors of poor control.
Pastori et al. (2020) conducted an observational in Mechanical prosthetic heart valves (n=2,111). Warfarin was evaluated on Low time in the therapeutic range (TiTR <60%). In patients with mechanical prosthetic heart valves on warfarin, 48.5% had a suboptimal time in therapeutic range (<60%), strongly associated with higher target INR ranges (OR 8.215 for 3.0-4.0).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: